RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults.

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial – JAMA

Commentary: China’s Sinopharm Publishes Awaited Covid Vaccine Study Details – Bloomberg

Commentary on Twitter (thread – click for more)

https://twitter.com/hildabast/status/1397678056270012419